These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 16311119

  • 1. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
    Chang Q, Pang JC, Li KK, Poon WS, Zhou L, Ng HK.
    Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
    [Abstract] [Full Text] [Related]

  • 2. [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor].
    Chang Q, Ng HK.
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):24-8. PubMed ID: 17374234
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
    Pang JC, Chang Q, Chung YF, Teo JG, Poon WS, Zhou LF, Kong X, Ng HK.
    Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
    [Abstract] [Full Text] [Related]

  • 4. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
    Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC.
    Cancer Res; 2002 Oct 15; 62(20):5906-11. PubMed ID: 12384556
    [Abstract] [Full Text] [Related]

  • 5. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM.
    Clin Cancer Res; 2003 Apr 15; 9(4):1441-5. PubMed ID: 12684417
    [Abstract] [Full Text] [Related]

  • 6. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
    Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP.
    Cancer Res; 2001 May 15; 61(10):3877-81. PubMed ID: 11358799
    [Abstract] [Full Text] [Related]

  • 7. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG.
    Cancer Res; 2001 Oct 01; 61(19):7034-8. PubMed ID: 11585730
    [Abstract] [Full Text] [Related]

  • 8. Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.
    Frühwald MC, O'Dorisio MS, Dai Z, Tanner SM, Balster DA, Gao X, Wright FA, Plass C.
    Oncogene; 2001 Aug 16; 20(36):5033-42. PubMed ID: 11526488
    [Abstract] [Full Text] [Related]

  • 9. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
    Frühwald MC, O'Dorisio MS, Smith L, Dai Z, Wright FA, Paulus W, Jürgens H, Plass C.
    Klin Padiatr; 2001 Aug 16; 213(4):197-203. PubMed ID: 11528554
    [Abstract] [Full Text] [Related]

  • 10. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas.
    Foja S, Goldberg M, Schagdarsurengin U, Dammann R, Tannapfel A, Ballhausen WG.
    Liver Int; 2005 Dec 16; 25(6):1202-8. PubMed ID: 16343073
    [Abstract] [Full Text] [Related]

  • 11. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
    Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AF.
    Oncogene; 2002 Jun 20; 21(27):4345-9. PubMed ID: 12082624
    [Abstract] [Full Text] [Related]

  • 12. Hypermethylation of the RASSF1A gene in gliomas.
    Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y.
    Clin Chim Acta; 2004 Nov 20; 349(1-2):173-9. PubMed ID: 15469871
    [Abstract] [Full Text] [Related]

  • 13. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 14. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P, Muñoz J, Nistal M, Pestaña A, Encío I, Castresana JS.
    BMC Cancer; 2006 Oct 25; 6():254. PubMed ID: 17064406
    [Abstract] [Full Text] [Related]

  • 15. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 16. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
    Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.
    Cancer Res; 2002 Jul 01; 62(13):3698-701. PubMed ID: 12097277
    [Abstract] [Full Text] [Related]

  • 17. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
    Mühlisch J, Schwering A, Grotzer M, Vince GH, Roggendorf W, Hagemann C, Sörensen N, Rickert CH, Osada N, Jürgens H, Frühwald MC.
    Oncogene; 2006 Feb 16; 25(7):1111-7. PubMed ID: 16186793
    [Abstract] [Full Text] [Related]

  • 18. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
    Inda MM, Muñoz J, Coullin P, Fauvet D, Danglot G, Tuñón T, Bernheim A, Castresana JS.
    Histopathology; 2006 Apr 16; 48(5):579-87. PubMed ID: 16623784
    [Abstract] [Full Text] [Related]

  • 19. Hypermethylation patterns in the Fhit regulatory region are tissue specific.
    Guler G, Iliopoulos D, Han SY, Fong LY, Lubet RA, Grubbs CJ, Huebner K.
    Mol Carcinog; 2005 Jul 16; 43(3):175-81. PubMed ID: 15937960
    [Abstract] [Full Text] [Related]

  • 20. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F.
    Oncogene; 2003 Jan 23; 22(3):461-6. PubMed ID: 12545168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.